Assignee profile:

BOLDER BIOTECHNOLOGY, INC.

City:

Boulder, Colorado

Country:

United States

Published Applications:

43

Last publication date:

2022-06-30

Patent Grants:

38

Last grant date:

2025-04-15

Top Inventors for applications by BOLDER BIOTECHNOLOGY, INC.

These are the the leading inventors for applications assigned to BOLDER BIOTECHNOLOGY, INC.:

Recent patent applications by BOLDER BIOTECHNOLOGY, INC.

BOLDER BIOTECHNOLOGY, INC. based in Boulder, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-06-30 ✅ Patent 12,274,736 granted on 2025-04-15
US20220202903A1
Human necessities

Hematopoietic growth factor proteins and analogs thereof and angiotensin converting enzyme inhibitors for treatment of radiation exposure

#2 | 2018-11-22 ✅ Patent 10,508,131 granted on 2019-12-17
US20180334475A1
Chemistry; metallurgy

Cysteine analogs of exendin-4

#3 | 2017-12-28 ✅ Patent 10,329,337 granted on 2019-06-25
US20170369547A1
Chemistry; metallurgy

Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11

#4 | 2017-03-23 ✅ Patent 11,229,683 granted on 2022-01-25
US20170080055A1
Human necessities

Hematopoietic growth factor proteins and analogs thereof and angiotensin converting enzyme inhibitors for treatment of radiation exposure

#5 | 2017-02-09 ✅ Patent 10,016,485 granted on 2018-07-10
US20170035852A1
Human necessities

Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure

#6 | 2016-07-14 ✅ Patent 9,637,530 granted on 2017-05-02
US20160200790A1
Chemistry; metallurgy

Methods of preparing cysteine variants of human recombinant IL-11

#7 | 2015-01-22 ✅ Patent 9,296,804 granted on 2016-03-29
US20150023918A1
Chemistry; metallurgy

NH2-terminal glutamine modified cysteine variants of interferon gamma

#8 | 2014-06-12
US20140163204A1
Chemistry; metallurgy

DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS

#9 | 2014-01-30 ✅ Patent 8,859,497 granted on 2014-10-14
US20140030225A1
Chemistry; metallurgy

Method of treatment using cysteine mutants of beta interferon

#10 | 2013-08-22 ✅ Patent 8,957,023 granted on 2015-02-17
US20130217629A1
Human necessities

Methods for making proteins containing free cysteine residues

#11 | 2012-11-15 ✅ Patent 9,320,777 granted on 2016-04-26
US20120288475A1
Human necessities

Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure

#12 | 2012-11-01 ✅ Patent 8,455,434 granted on 2013-06-04
US20120276042A1
Chemistry; metallurgy

Methods of use for cysteine variants of human G-CSF

#13 | 2012-09-13 ✅ Patent 8,748,392 granted on 2014-06-10
US20120231040A1
Chemistry; metallurgy

Methods of treatment using cysteine variants of interleukin-11

#14 | 2012-03-15 ✅ Patent 8,288,126 granted on 2012-10-16
US20120064573A1
Chemistry; metallurgy

Methods for making proteins containing free cysteine residues

#15 | 2011-08-04 ✅ Patent 8,932,828 granted on 2015-01-13
US20110189124A1
Chemistry; metallurgy

Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins

#16 | 2011-07-14 ✅ Patent 8,148,500 granted on 2012-04-03
US20110172151A1
Human necessities

Method of preparing cysteine mutants of human recombinant GM-CSF

#17 | 2010-11-11
US20100285014A1
Chemistry; metallurgy

IMMUNOGLOBULIN FUSION PROTEINS

#18 | 2010-10-21 ✅ Patent 7,994,124 granted on 2011-08-09
US20100266529A1
Chemistry; metallurgy

Methods of use of G-CSF cysteine muteins

#19 | 2010-07-13 ✅ Patent 7,754,855 granted on 2010-07-13
US10031154
-

Immunoglobulin fusion proteins

#20 | 2010-06-08 ✅ Patent 7,732,572 granted on 2010-06-08
US10866540
-

Cysteine variants of alpha interferon-2

#21 | 2010-05-13 ✅ Patent 8,617,531 granted on 2013-12-31
US20100121032A1
Chemistry; metallurgy

Methods of making proteins and peptides containing a single free cysteine

#22 | 2010-02-25 ✅ Patent 7,947,655 granted on 2011-05-24
US20100048872A1
Chemistry; metallurgy

Methods for making proteins containing free cysteine residues

#23 | 2010-02-04 ✅ Patent 7,824,669 granted on 2010-11-02
US20100029563A1
Human necessities

In vivo stimulation of peripheral blood progenitor cells by granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine muteins and their PEGylated variants

#24 | 2009-11-12 ✅ Patent 8,133,480 granted on 2012-03-13
US20090281281A1
Chemistry; metallurgy

Cysteine variants of interleukin-11

#25 | 2009-10-29
US20090269804A1
Chemistry; metallurgy

Methods for refolding proteins containing free cysteine residues

#26 | 2009-06-25 ✅ Patent 8,329,866 granted on 2012-12-11
US20090163411A1
Chemistry; metallurgy

Long acting VEGF inhibitors and methods of use

#27 | 2009-03-05
US20090060863A1
Chemistry; metallurgy

DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS

#28 | 2008-12-25 ✅ Patent 7,959,909 granted on 2011-06-14
US20080317713A1
Chemistry; metallurgy

Cysteine variants of interferon gamma

#29 | 2008-09-11 ✅ Patent 7,964,184 granted on 2011-06-21
US20080219950A1
Chemistry; metallurgy

Cysteine variants of interferon-gamma

#30 | 2008-03-27
US20080076706A1
Chemistry; metallurgy

Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof

#31 | 2007-12-18 ✅ Patent 7,309,781 granted on 2007-12-18
US10856219
-

Cysteine variants of granulocyte colony-stimulating factor

#32 | 2007-12-11 ✅ Patent 7,306,931 granted on 2007-12-11
US10276358
-

Method for refolding proteins containing free cysteine residues

#33 | 2007-11-01 ✅ Patent 7,560,101 granted on 2009-07-14
US20070253929A1
Human necessities

Method of treatment of an infection in an animal with GM-CSF cysteine muteins in the proximal region to helix A

#34 | 2007-05-17 ✅ Patent 7,495,087 granted on 2009-02-24
US20070111240A1
Chemistry; metallurgy

Cysteine muteins in the C-D loop of human interleukin-11

#35 | 2007-05-08 ✅ Patent 7,214,779 granted on 2007-05-08
US10773654
-

Termini cysteine-added variants of granulocyte-macrophage colony stimulating factor

#36 | 2006-12-26 ✅ Patent 7,153,943 granted on 2006-12-26
US10298148
-

Derivatives of growth hormone and related proteins, and methods of use thereof

#37 | 2006-12-12 ✅ Patent 7,148,333 granted on 2006-12-12
US10400377
-

Cysteine variants of granulocyte-macrophage colony-stimulating factor

#38 | 2005-10-13 ✅ Patent 7,345,149 granted on 2008-03-18
US20050227330A1
Chemistry; metallurgy

Cysteine substitution variants of beta interferon

#39 | 2005-09-29 ✅ Patent 7,795,396 granted on 2010-09-14
US20050214254A1
Chemistry; metallurgy

COOH-terminally added cysteine variant of the beta interferon

#40 | 2005-08-25 ✅ Patent 7,399,839 granted on 2008-07-15
US20050187160A1
Chemistry; metallurgy

Monopegylated growth hormone proteins

#41 | 2005-05-19 ✅ Patent 7,345,154 granted on 2008-03-18
US20050107591A1
Chemistry; metallurgy

Cysteine variants of erythropoietin

#42 | 2005-03-17 ✅ Patent 7,270,809 granted on 2007-09-18
US20050058621A1
Chemistry; metallurgy

Cysteine variants of alpha interferon-2

#43 | 2005-02-03 ✅ Patent 7,629,314 granted on 2009-12-08
US20050026834A1
Chemistry; metallurgy

Methods for making proteins containing free cysteine residues

Also check out Bolder BioTechnology, Inc.'s (Boulder, United States) applicant profile with 10 patent applications submitted.

AssigneeID:

36038 ⎘